Engineered Mesenchymal Stem Cell–NK Cell Complexes for Spatially Targeted and Functionally Revitalized Cancer Immunotherapy
Advanced Science · 2026-06 · 13 (35)
DOI: 10.1002/advs.202509638 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 19.08.2025. Verfasst von Qian Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Respiratory and Critical Care, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China. Hauptthemen laut MEDLINE: Killer Cells, Natural, Mesenchymal Stem Cells, Immunotherapy, Interleukin-15. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Foundation of Education Department of Anhui Province of China.
Abstract (Originalsprache)
Natural killer (NK) cells represent a powerful immunotherapeutic strategy due to their intrinsic cytotoxicity and ability to target tumor cells independently of antigen presentation. However, their clinical efficacy against solid tumors is limited by poor tumor infiltration and impaired functionality within the immunosuppressive microenvironment. Here, a genetically engineered cell‐cell complex delivery system comprising NK cells conjugated to IL‐15 expressing adipose‐derived mesenchymal stem cells (SCs) is developed. By exploiting SCs’ intrinsic tumor‐tropic properties and engineering them to consistently express interleukin‐15 (IL‐15) via lipid nanoparticle‐mediated mRNA transfection, the SC‐NK cell complexes exhibit markedly improved tumor localization and sustained cytokine‐mediated functional enhancement. Utilizing bioorthogonal click chemistry for precise conjugation, the approach effectively enhances NK cell infiltration and revitalizes their cytotoxic activity in both orthotopic murine lung cancer and patient‐derived xenograft ovarian cancer models. Furthermore, increased responsiveness of the cell‐cell complexes to Galectin‐9 blockade therapy is identified, leading to the reversal of NK cell dysfunction and significantly augmented antitumor efficacy. Collectively, the engineered SC‐assisted delivery system holds potential for overcoming the limitations of NK cell therapies and improving their therapeutic outcomes in solid tumor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatric Respiratory and Critical Care, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
- Department of General Practice, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
- Department of Geriatrics, Renhe Hospital of Shanghai University, Shanghai, 200431, China.
- Department of Geriatrics Center & National Clinical Research Center for Aging and Medicine, Jing'an District Central Hospital of Shanghai, Fudan University, Shanghai, 200040, China.
- Department of Obstetrics and Gynecology, the First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
- Institute of Medical Genetics and Development, Key Laboratory of Reproductive Genetics (Ministry of Education) and Women's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
ORCID-Profile: Jiong Wang
Förderung
- Scientific Research Foundation of Education Department of Anhui Province of China
Zitieren
APA
Zhang, Q., Yin, B., Sabier, M., Yang, Y., Wu, M., Zhao, Z., Luo, X., Zhong, Y., Zhu, X., Zhang, J., Wang, J., Chen, K., Ruan, F., Zhang, W., Lu, Z., & Wang, J. (2026). Engineered Mesenchymal Stem Cell–NK Cell Complexes for Spatially Targeted and Functionally Revitalized Cancer Immunotherapy. Advanced Science, 13(35). https://doi.org/10.1002/advs.202509638
Vancouver
Zhang Q, Yin B, Sabier M, Yang Y, Wu M, Zhao Z, et al. Engineered Mesenchymal Stem Cell–NK Cell Complexes for Spatially Targeted and Functionally Revitalized Cancer Immunotherapy. Advanced Science. 2026;13(35). doi:10.1002/advs.202509638
BibTeX
@article{Zhang2026,
author = {Zhang, Qian and Yin, Bo and Sabier, Munaiwaier and Yang, Youlan and Wu, Mengling and Zhao, Zhouping and Luo, Xuanzhi and Zhong, Yuehong and Zhu, Xiuming and Zhang, Jie and Wang, Jing and Chen, Kai and Ruan, Fei and Zhang, Wei and Lu, Zhimin and Wang, Jiong},
title = {Engineered Mesenchymal Stem Cell–NK Cell Complexes for Spatially Targeted and Functionally Revitalized Cancer Immunotherapy},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {35},
doi = {10.1002/advs.202509638}
}
EUVIMED